FDA Recognizes March Biosciences’ MB-105 with RMAT Status
By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class...

By Daniella Parra March Biosciences said that the FDA granted regenerative medicine advanced therapy its first-in-class...
By Daniella Parra Radiant Biotherapeutics presented data from their advancing a breakthrough antibody approach, the...
By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it appointed Adam S. Elinoff as...
By Karen Roman Biopharmaceutical company Medera Inc. said the first patient has been dosed in...
By Karen Roman Oncology-focused biotech company SkylineDx said results from its MERLIN_001 trial, the largest...
By Daniella Parra Ashvattha Therapeutics has appointed Robert J. Dempsey as Interim CEO, tapping an ophthalmology...
By Karen Roman Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it started a global product license...
By Daniella Parra NanoCell Therapeutics, Inc. has appointed three new members to its Scientific Advisory...
By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA) said a study led by The University of...
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said it is collaborating with Monarch Medical...